2-Propyl-4-methyl-6-(1-methylbenzimidazole-2-yl)benzimidazole 98%

Founded in 2014 as a division of K P Manish Global Ingredients Pvt Ltd, Kawman Pharma has emerged as a pioneering force in the API manufacturing industry.   With commercial production commencing in Nov'16, our journey has been marked by an unwavering commitment to excellence and innovation.

Kawman stands as an emerging API manufacturer, providing vital pharmaceutical ingredients to numerous nations globally.   At the core of Kawman Pharma's API prowess lie advanced chemistry expertise, efficient and cost-effective manufacturing, unwavering dedication to quality, and cutting-edge production facilities.

Our commitment to excellence is exemplified through a strategic approach, including backward integration to ensure a steady supply of quality raw materials, operational efficiency, a resilient supply chain network spanning diverse geographies, and formidable collaborative efforts tailored to meet the unique needs of our valued customers.   This multifaceted approach firmly establishes Kawman as the most trusted API partner, both within India and on the international stage.